Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-05 5:34 pm Sale | 2023-12-29 | 13G | RIGEL PHARMACEUTICALS INC RIGL | GOLDMAN SACHS GROUP INC GS | 25,568 0.100% | -911,438 (-97.27%) | Filing History |
| 2024-02-02 09:56 am Purchase | 2023-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Soleus Capital Master Fund L.P. | 944,258 5.400% | 21,956 (+2.38%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | BlackRock, Inc. BLK | 1,519,808 8.700% | 51,702 (+3.52%) | Filing History |
| 2023-06-12 08:21 am Sale | 2023-06-09 | 13G | RIGEL PHARMACEUTICALS INC RIGL | FMR LLC | 20,082 0.115% | -869,119 (-97.74%) | Filing History |
| 2023-02-22 4:03 pm Purchase | 2023-02-21 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Soleus Capital Master Fund L.P. | 922,302 5.300% | 922,302 (New Position) | Filing History |
| 2023-02-14 2:40 pm Purchase | 2022-12-30 | 13G | RIGEL PHARMACEUTICALS INC RIGL | GOLDMAN SACHS GROUP INC GS | 937,006 5.400% | 937,006 (New Position) | Filing History |
| 2023-02-14 1:21 pm Purchase | 2022-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Armistice Capital, LLC | 1,695,600 9.810% | 1,695,600 (New Position) | Filing History |
| 2023-02-09 12:31 pm Sale | 2023-02-09 | 13G | RIGEL PHARMACEUTICALS INC RIGL | FMR LLC | 889,201 5.144% | -659,458 (-42.58%) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | RIGEL PHARMACEUTICALS INC RIGL | VANGUARD GROUP INC | 1,208,380 6.990% | 305,569 (+33.85%) | Filing History |
| 2023-02-06 1:20 pm Sale | 2022-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | STATE STREET CORP STT | 337,491 1.950% | -50,316 (-12.97%) | Filing History |
| 2023-02-03 4:27 pm Sale | 2022-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | BlackRock, Inc. BLK | 1,468,106 8.500% | -187,092 (-11.30%) | Filing History |
| 2022-10-11 2:06 pm Sale | 2022-09-30 | 13G | RIGEL PHARMACEUTICALS INC RIGL | STATE STREET CORP STT | 387,807 2.240% | -2,006,750 (-83.80%) | Filing History |
| 2022-10-11 09:03 am Sale | 2022-10-07 | 13G | RIGEL PHARMACEUTICALS INC RIGL | FMR LLC | 1,548,659 8.960% | -908,500 (-36.97%) | Filing History |
| 2022-09-22 4:02 pm Purchase | 2022-09-16 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Integrated Core Strategies (US) LLC | 759,112 4.400% | 759,112 (New Position) | Filing History |
| 2022-07-11 11:46 am Purchase | 2022-06-30 | 13G | RIGEL PHARMACEUTICALS INC RIGL | STATE STREET CORP STT | 2,394,557 13.920% | 1,537,976 (+179.55%) | Filing History |
| 2022-02-11 7:55 pm Sale | 2021-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | STATE STREET CORP STT | 856,581 5.010% | -79,669 (-8.51%) | Filing History |
| 2022-02-10 08:32 am Sale | 2021-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | VANGUARD GROUP INC | 902,811 5.280% | -11,749 (-1.28%) | Filing History |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | RIGEL PHARMACEUTICALS INC RIGL | FMR LLC | 2,457,159 14.368% | 365,849 (+17.49%) | Filing History |
| 2022-02-01 5:08 pm Sale | 2021-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | BlackRock, Inc. BLK | 1,655,198 9.700% | -94,144 (-5.38%) | Filing History |
| 2021-09-10 08:54 am Sale | 2021-08-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Wellington Management Group LLP | 140,620 0.820% | -979,237 (-87.44%) | Filing History |